Abivax Phase 3 Program with Obefazimod in Ulcerative Colitis Progresses with US IRB Approval

Phase 3 clinical induction study protocols for obefazimod in ulcerative colitis (UC) are approved by central US IRB (Institutional Review Board)Start-up activities are on track and FPI (First-Patient-In) expected in the US by end Q3 2022First …